Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Nasdaq / Amgen

Nasdaq & Amgen

2 shared events · Importance 3 · Last updated Aug 05, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
28
Business
Scribe Therapeutics upsized IPO closes
Nasdaq: Nasdaq is the exchange where Scribe's shares began trading, benefiting from listing fees and increased trading activity.
Amgen: Amgen's Repatha is a competitor to Scribe's STX-1150 in the PCSK9 inhibitor space. The success of Scribe's therapy could impact Amgen's market share in cholesterol management.
Jul 06, 2026 · 25 articles
7
Business
Spero Therapeutics appoints new CMO
Nasdaq: Nasdaq is the exchange where Spero Therapeutics is listed under ticker SPRO.
Amgen: Amgen is mentioned as a previous employer of Dr. Zack, where she served as Global Development Lead for Enbrel.
Jul 27, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Nasdaq and Amgen interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.